Endothelial Progenitor Cells in Long-Standing Asymptomatic Type 1 Diabetic Patients with or without Diabetic Nephropathy

被引:7
作者
Reinhard, Henrik [1 ]
Jacobsen, Peter Karl [1 ,5 ]
Lajer, Maria [1 ]
Tarnow, Lise [1 ]
Astrup, Anne Sofie [1 ]
Kim, Won Yong [3 ,4 ]
Pedersen, Nadja [1 ]
Billestrup, Nils [1 ]
Mandrup-Poulsen, Thomas [2 ,6 ,9 ]
Parving, Hans-Henrik [7 ,8 ]
Rossing, Peter [1 ]
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Hagedorn Res Inst, Dept Translat Diabetol, Gentofte, Denmark
[3] Skejby Hosp, Dept Cardiol, Skejby, Denmark
[4] Skejby Hosp, MR Ctr, Skejby, Denmark
[5] Rigshosp, Ctr Heart, DK-2100 Copenhagen, Denmark
[6] Univ Copenhagen, Dept Biomed Sci, Core Unit Med Res Methodol, Copenhagen, Denmark
[7] Univ Copenhagen Hosp, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark
[8] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark
[9] Karolinska Inst, Dept Med & Surg, Stockholm, Sweden
来源
NEPHRON CLINICAL PRACTICE | 2011年 / 118卷 / 03期
关键词
Cardiovascular disease; Diabetes mellitus; Diabetic nephropathy; Endothelial progenitor cells; CORONARY-ARTERY-DISEASE; ASYMMETRIC DIMETHYLARGININE; STATIN THERAPY; NITRIC-OXIDE; RISK-FACTORS; DYSFUNCTION; REENDOTHELIALIZATION; PROLIFERATION; ADHESION; INCREASE;
D O I
10.1159/000322667
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A decrease in the number and dysfunction of endothelial progenitor cells (EPC) may increase the risk for progression of cardiovascular disease (CVD) in type 1 diabetic patients with diabetic nephropathy (DN). Our aim was to evaluate EPC numbers in asymptomatic CVD type 1 diabetic patients with or without DN and to study the effect of CVD and medication on EPC numbers. Methods: We examined EPC numbers in 37 type 1 diabetic patients with DN and 35 type 1 diabetic patients with long-standing normoalbuminuria. Patients were without symptoms of CVD and the prevalence of CVD was previously shown to be very low. EPC number was assessed in in vitro cultures by fluorescent staining of attached cells. Results: There was no difference in EPC numbers between patients with DN (mean +/- SD 120 +/- 49 cells/field) and normoalbuminuria (108 +/- 41 cells/field; p = 0.25). Furthermore, EPC number was not associated with CVD (p > 0.05). Conventional risk factors were significantly higher in patients with DN and they received more CVD-preventive treatment. All patients receiving simvastatin or calcium-channel blockers had higher numbers of EPC compared to patients not treated with these drugs. Conclusions: Asymptomatic patients with DN had EPC numbers similar to normoalbuminuric patients, which was related to aggressive CVD intervention therapy. This may have contributed to the low prevalence of CVD. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:C309 / C314
页数:6
相关论文
共 29 条
[1]   Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [J].
Asahara, T ;
Masuda, H ;
Takahashi, T ;
Kalka, C ;
Pastore, C ;
Silver, M ;
Kearne, M ;
Magner, M ;
Isner, JM .
CIRCULATION RESEARCH, 1999, 85 (03) :221-228
[2]   Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study [J].
Astrup, AS ;
Tarnow, L ;
Rossing, P ;
Pietraszek, L ;
Hansen, PR ;
Parving, HH .
KIDNEY INTERNATIONAL, 2005, 68 (03) :1250-1257
[3]   Stimulation of endothelial progenitor cells - A new putative therapeutic effect of angiotensin II receptor antagonists [J].
Bahlmann, FH ;
de Groot, K ;
Mueller, O ;
Hertel, B ;
Haller, H ;
Fliser, D .
HYPERTENSION, 2005, 45 (04) :526-529
[4]   Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin - Rapid communication [J].
Bahlmann, FH ;
DeGroot, K ;
Duckert, T ;
Niemczyk, E ;
Bahlmann, E ;
Boehm, SM ;
Haller, H ;
Fliser, D .
KIDNEY INTERNATIONAL, 2003, 64 (05) :1648-1652
[5]   Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular Disease [J].
Chade, Alejandro R. ;
Zhu, Xiangyang ;
Lavi, Ronit ;
Krier, James D. ;
Pislaru, Sorin ;
Simari, Robert D. ;
Napoli, Claudio ;
Lerman, Amir ;
Lerman, Lilach O. .
CIRCULATION, 2009, 119 (04) :547-U121
[6]   Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure [J].
Choi, JH ;
Kim, KL ;
Huh, W ;
Kim, B ;
Byun, J ;
Suh, W ;
Sung, J ;
Jeon, ES ;
Oh, HY ;
Kim, DK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) :1246-1252
[7]   Endothelial function and dysfunction - Testing and clinical relevance [J].
Deanfield, John E. ;
Halcox, Julian P. ;
Rabelink, Ton J. .
CIRCULATION, 2007, 115 (10) :1285-1295
[8]   HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway [J].
Dimmeler, S ;
Aicher, A ;
Vasa, M ;
Mildner-Rihm, C ;
Adler, K ;
Tiemann, M ;
Rütten, H ;
Fichtlscherer, S ;
Martin, H ;
Zeiher, AM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :391-397
[9]   Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau [J].
Fadini, Gian Paolo ;
Baesso, Ilenia ;
Albiero, Mattia ;
Sartore, Saverio ;
Agostini, Carlo ;
Avogaro, Angelo .
ATHEROSCLEROSIS, 2008, 197 (02) :496-503
[10]   Low CD34+cell count and metabolic syndrome synergistically increase the risk of adverse outcomes [J].
Fadini, Gian Paolo ;
de Kreutzenberg, Saula ;
Agostini, Carlo ;
Boscaro, Elisa ;
Tiengo, Antonio ;
Dimmeler, Stefanie ;
Avogaro, Angelo .
ATHEROSCLEROSIS, 2009, 207 (01) :213-219